Curaleaf Holdings Statistics

Total Valuation

TSX:CURA has a market cap or net worth of CAD 923.95 million. The enterprise value is 2.49 billion.

Market Cap	923.95M
Enterprise Value	2.49B

Important Dates

The last earnings date was Wednesday, May 7, 2025.

Earnings Date	May 7, 2025
Ex-Dividend Date	n/a

Share Statistics

TSX:CURA has 757.33 million shares outstanding. The number of shares has increased by 1.97% in one year.

Current Share Class	663.36M
Shares Outstanding	757.33M
Shares Change (YoY)	+1.97%
Shares Change (QoQ)	+0.15%
Owned by Insiders (%)	19.58%
Owned by Institutions (%)	11.06%
Float	602.97M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.49
PB Ratio	0.67
P/TBV Ratio	n/a
P/FCF Ratio	10.27
P/OCF Ratio	4.04
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.75, with an EV/FCF ratio of 27.65.

EV / Earnings	-6.55
EV / Sales	1.32
EV / EBITDA	5.75
EV / EBIT	113.00
EV / FCF	27.65

Financial Position

The company has a current ratio of 1.41, with a Debt / Equity ratio of 1.10.

Current Ratio	1.41
Quick Ratio	0.59
Debt / Equity	1.10
Debt / EBITDA	3.52
Debt / FCF	16.95
Interest Coverage	0.15

Financial Efficiency

Return on equity (ROE) is -20.92% and return on invested capital (ROIC) is 0.45%.

Return on Equity (ROE)	-20.92%
Return on Assets (ROA)	0.32%
Return on Invested Capital (ROIC)	0.45%
Return on Capital Employed (ROCE)	0.58%
Revenue Per Employee	342,182
Profits Per Employee	-68,819
Employee Count	5,519
Asset Turnover	0.44
Inventory Turnover	3.06

Taxes

In the past 12 months, TSX:CURA has paid 157.52 million in taxes.

Income Tax	157.52M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -80.82% in the last 52 weeks. The beta is 1.14, so TSX:CURA's price volatility has been higher than the market average.

Beta (5Y)	1.14
52-Week Price Change	-80.82%
50-Day Moving Average	1.23
200-Day Moving Average	2.53
Relative Strength Index (RSI)	49.31
Average Volume (20 Days)	352,090

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TSX:CURA had revenue of CAD 1.89 billion and -379.81 million in losses. Loss per share was -0.51.

Revenue	1.89B
Gross Profit	910.59M
Operating Income	22.02M
Pretax Income	-178.35M
Net Income	-379.81M
EBITDA	353.54M
EBIT	22.02M
Loss Per Share	-0.51

Full Income Statement

Balance Sheet

The company has 175.17 million in cash and 1.53 billion in debt, giving a net cash position of -1.35 billion or -1.78 per share.

Cash & Cash Equivalents	175.17M
Total Debt	1.53B
Net Cash	-1.35B
Net Cash Per Share	-1.78
Equity (Book Value)	1.38B
Book Value Per Share	1.55
Working Capital	186.41M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 228.58 million and capital expenditures -138.58 million, giving a free cash flow of 90.00 million.

Operating Cash Flow	228.58M
Capital Expenditures	-138.58M
Free Cash Flow	90.00M
FCF Per Share	0.12

Full Cash Flow Statement

Margins

Gross margin is 48.22%, with operating and profit margins of 1.17% and -17.37%.

Gross Margin	48.22%
Operating Margin	1.17%
Pretax Margin	-9.44%
Profit Margin	-17.37%
EBITDA Margin	18.72%
EBIT Margin	1.17%
FCF Margin	4.77%

Dividends & Yields

TSX:CURA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.97%
Shareholder Yield	n/a
Earnings Yield	-41.11%
FCF Yield	9.74%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TSX:CURA has an Altman Z-Score of 0.52 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.52
Piotroski F-Score	1